Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Muscular Dystrophy Article
This is a selection made from among articles on Drug Treatment Muscular Dystrophy. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
What You Need To Know About Drug And Alcohol Addiction Treatment Programs
By Sandy Sizemore
A drug and alcohol addiction treatment program is one of the most successful ways to wean yourself from drugs, alcohol and all other addicting processes. If you are at the stage where you are considering drug and alcohol addiction recovery, the good news is that you are on the road to recovery. The bad news is that this is a long and very difficult journey that you will have to take. A drug rehab clinic is often one of the best ways for you to detox from alcohol and drug use. But, you need to do so with the necessary knowledge about the drug and alcohol addiction treatment program you plan to attend.
Here are some fundamental things to consider about the drug and alcohol addiction treatment program you are considering.
· Your drug rehab clinic should provide help for all areas of the infected person. That includes their psychological, medical, and legal problems.
It can also address their needs for finding a way to work and overall restart their life.
· Realize that not all treatment programs are the same for everyone. You should work with the clinic to determine the most appropriate treatment program for your specific circumstances.
· The program should allow for continuous change to it, as the individual grows through it. As they begin to repair the damage done to them by drugs, the effective treatment program should change to accommodate these needs.
· Time is needed. It is necessary for a person to stay in treatment for as long as possible. On average, this is about three full months. Only with enough time will the treatment be successful.
· The drug and alcohol addiction treatment program also needs to focus on the medicinal needs of the patient. That would mean careful consideration for their specific medical concerns. Things like withdrawal medications are almost always necessary in severely addicted individuals.
· You should realize that detoxifying the individual is not enough to stop the behavior. The drug rehab clinic needs to handle more than just this process. It needs to look for the long term rehabilitation of the individual. Detoxing is just not enough.
· Also, you should take note that voluntary drug treatment is not always necessary. If a person is motivated to detox because of family, employment or legal problems, this can be enough to push them through it.
Additionally, this force to go in can help them to become more successful at their program as well.
Drug and alcohol addiction recovery does and can happen through a high quality drug and alcohol addiction treatment program. Once the alcohol and drug detox has happened, the next step is to correct the behavioral, emotional, physical and long term effects of the drugs. This can be the mark of healing when the program addresses the full scope of what is happening.
Sandy Sizemore writes on many consumer related topics including mental health. You can find a drug rehab clinic and a drug abuse treatment center and more by visiting our mental health website.
Article Source: http://EzineArticles.com/?expert=Sandy_Sizemore
http://EzineArticles.com/?What-You-Need-To-Know-About-Drug-And-Alcohol-Addiction-Treatment-Programs&id=203195
Drug Treatment Muscular Dystrophy Specific links
Drug Treatment Muscular Dystrophy News
Summit Corporation PLC : Summit Announces Initiation of Phase 1 Trial for the ... - MarketWatch (press release)
Summit Corporation PLC : Summit Announces Initiation of Phase 1 Trial for the ... MarketWatch (press release) ... May 25, 2012 (MARKETWIRE via COMTEX) -- Summit (aim:SUMM), a UK drug discovery company, today announced that it has dosed the first cohort of patients in a Phase 1 study of SMT C1100 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal, ... Halo Gathers $1.1M From Patient Groups for Muscular Dystrophy Drug |
Medical marijuana brings relief for sick kids in Michigan but the treatment is ... - Detroit Free Press
Medical marijuana brings relief for sick kids in Michigan but the treatment is ... Detroit Free Press Parents say they've successfully used medical cannabis to treat their kids for Dravet Syndrome, which Cooper has, as well as autism, attention deficit disorder, muscular dystrophy, and the pain and nausea of cancer, among other ailments. |
Taking a muscular approach towards diabetes and other diseases - HealthCanal.com
Taking a muscular approach towards diabetes and other diseases HealthCanal.com Australian scientists have identified a gene that regulates muscle size, a finding that could help unlock therapies for Type 2 diabetes and diseases such as muscular dystrophy, where muscles are weakened and damaged. Type 2 diabetes occurs when the ... |
Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 - Sacramento Bee
Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 Sacramento Bee The drug candidate has received Orphan status in both the US and the EU. "The community of muscular dystrophy foundations has rallied around our novel and aggressive approach to delivering a promising therapy to DMD boys and their families," said Tom ... |
Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 - PR Newswire (press release)
Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 PR Newswire (press release) Halo will use the funds to expedite the phase 2 study of HT-100, its lead drug candidate for Duchenne muscular dystrophy (DMD). HT-100, a proprietary formulation of halofuginone, is an orally available small molecule drug candidate being developed to ... |
Medical Treatments From 200 Miles Up - Inside Science News Service
Medical Treatments From 200 Miles Up Inside Science News Service It can provide better drug delivery and new medical treatments for solid tumors and resistant infections. Those encapsulated drugs could be directly injected into a tumor and would go to work destroying the cancer from the inside out. |
MDA Supports Development of 'Dissociative Glucocorticoid' for DMD - MarketWatch (press release)
MDA Supports Development of 'Dissociative Glucocorticoid' for DMD MarketWatch (press release) The Muscular Dystrophy Association announced today that it has awarded $1549725 to ReveraGen BioPharma, a Rockville, Md., biotechnology company, to develop and test a "dissociative glucocorticoid" as a potential treatment for Duchenne muscular ... |
Scientists Discover Clues to Muscle Stem Cell Functions - Newswise (press release)
Scientists Discover Clues to Muscle Stem Cell Functions Newswise (press release) “We found that mdx mice, which have a disease similar to Duchenne Muscular Dystrophy, are deficient in S1P. We were able to increase the S1P levels in the mice using a drug that blocks S1P breakdown. This treatment increased the number of satellite ... |
PPMD Holds Landmark Meeting with FDA Leaders to Address Trial Design, Endpoint ... - MarketWatch (press release)
PPMD Holds Landmark Meeting with FDA Leaders to Address Trial Design, Endpoint ... MarketWatch (press release) Parent Project Muscular Dystrophy (PPMD) - the leading advocacy organization fighting to end Duchenne muscular dystrophy, the most common form of muscular dystrophy, convened a high-impact meeting with leaders of the Food & Drug Administration's (FDA) ... |
Retrophin, LLC Completes Series A Financing - MarketWatch (press release)
Retrophin, LLC Completes Series A Financing MarketWatch (press release) "With our Series A complete, we're in position to advance our lead compound, RE-021, through proof of concept, as well to continue development of RE-001 for the treatment of Duchene Muscular Dystrophy." Retrophin, LLC is a privately-held New York-based ... |